A Bispecific, Tetravalent Antibody Targeting Inflammatory and Pruritogenic Pathways in Atopic Dermatitis

Inhibition of IL-4/IL-13 signaling has dramatically improved the treatment of atopic dermatitis (AD). However, in many patients, clinical responses are slow to develop and remain modest. Indeed, some symptoms of AD are dependent on IL-31, which is only partially reduced by IL-4/IL-13 inhibition. Thu...

Description complète

Détails bibliographiques

Auteurs principaux:	Julia Tietz, Tea Gunde, Stefan Warmuth, Christopher Weinert, Matthias Brock, Alexandre Simonin, Christian Hess, Maria Johansson, Fabio Spiga, Simone Muntwiler, Belinda Wickihalder, Dana Mahler, Dania Diem, Julia Zeberer, Robin Heiz, Naomi Flückiger, Noriko Shiraishi, Yoshihide Miyake, Nobuaki Takahashi, Markus Fehrholz, Marta Bertolini, Peter Lichtlen, David Urech, Daniel Snell
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2024-03-01
Collection:	JID Innovations
Sujets:	Atopic dermatitis Cytokines Inflammatory skin diseases Pruritus
Accès en ligne:	http://www.sciencedirect.com/science/article/pii/S2667026724000043
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!